68Ga-PSMA-11 PET has the potential to improve patient selection for extended pelvic lymph node dissection in intermediate to high-risk prostate cancer

被引：0

作者：

Daniela A. Ferraro

Urs J. Muehlematter

Helena I. Garcia Schüler

Niels J. Rupp

Martin Huellner

Michael Messerli

Jan Hendrik Rüschoff

Edwin E. G. W. ter Voert

Thomas Hermanns

Irene A. Burger

机构：

[1] University Hospital Zurich,Department of Nuclear Medicine

[2] University of Zurich,Institute of Diagnostic and Interventional Radiology

[3] University Hospital Zurich,Department of Radiation Oncology

[4] University of Zurich,Department of Pathology and Molecular Pathology

[5] University Hospital Zurich,Department of Urology

[6] University of Zurich,Department of Nuclear Medicine

[7] University Hospital Zurich,undefined

[8] University of Zurich,undefined

[9] University Hospital Zurich,undefined

[10] University of Zurich,undefined

[11] Kantonsspital Baden,undefined

来源：

European Journal of Nuclear Medicine and Molecular Imaging | 2020年 / 47卷

关键词：

SUV; PET quantification; Lymph node metastases; PET/MR; PET/CT; Staging; Prediction model; Nomogram; Net benefit;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：147 / 159

页数：12

共 50 条

[41] 68Ga-PSMA-11 dynamic PET/CT in the diagnostics of primary prostate cancer
Sachpekidis, C.
Eder, M.
Kopka, K.
Mier, W.
Hadaschik, B. A.
Haberkorn, U.
Dimitrakopoulou-Strauss, A.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S669 - S669
[42] A Comprehensive Safety Evaluation of 68Ga-PSMA-11 PET/CT in Prostate Cancer
Nielsen, Julie B.
Zacho, Helle D.
Haberkorn, Uwe
Nielsen, Karin M.
Dettmann, Katja
Langkilde, Niels C.
Petersen, Lars J.
CLINICAL NUCLEAR MEDICINE, 2017, 42 (07) : 520 - 524
[43] Development and external validation of a multivariable [68Ga]Ga-PSMA-11 PET-based prediction model for lymph node involvement in men with intermediate or high-risk prostate cancer
Muehlematter, Urs J.
Schweiger, Lilit
Ferraro, Daniela A.
Hermanns, Thomas
Maurer, Tobias
Heck, Matthias M.
Rupp, Niels J.
Eiber, Matthias
Rauscher, Isabel
Burger, Irene A.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (10) : 3137 - 3146
[44] Assessment of 68Ga-PSMA-11 PET positivity predictive factors in prostate cancer
Gutierrez-Cardo, A. L.
Perez Duarte, A.
Garcia-Arguello, S. F.
Lopez Lorenzo, B.
Lillo Garcia, M. E.
Valdivielso, P.
REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2019, 38 (01): : 22 - 28
[45] 68Ga-PSMA-11 dynamic PET/CT in biochemical relapse of prostate cancer
Sachpekidis, C.
Eder, M.
Kopka, K.
Mier, W.
Hadaschik, B. A.
Dimitrakopoulou-Strauss, A.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S670 - S670
[46] 68Ga-PSMA PET/CT for Primary Lymph Node and Distant Metastasis NM Staging of High-Risk Prostate Cancer
Klingenberg, Soren
Jochumsen, Mads R.
Ulhoi, Benedicte P.
Fredsoe, Jacob
Sorensen, Karina D.
Borre, Michael
Bouchelouche, Kirsten
JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (02) : 214 - 220
[47] 18F-fluorocholine PET/CT compared with extended pelvic lymph node dissection in high-risk prostate cancer
H. Kjölhede
G. Ahlgren
H. Almquist
F. Liedberg
K. Lyttkens
T. Ohlsson
O. Bratt
World Journal of Urology, 2014, 32 : 965 - 970
[48] 18F-fluorocholine PET/CT compared with extended pelvic lymph node dissection in high-risk prostate cancer
Kjolhede, H.
Ahlgren, G.
Almquist, H.
Liedberg, F.
Lyttkens, K.
Ohlsson, T.
Bratt, O.
WORLD JOURNAL OF UROLOGY, 2014, 32 (04) : 965 - 970
[49] Can pelvic lymph node dissection be skipped in prostate cancer patient based on PSMA-PET?
Chan, M. W. L.
Chan, V.
Wong, C. H. M.
Wong, F. C. H.
Chan, S. Y. S.
Li, J. K. M.
Chan, W. H. C.
Ng, A. C. F.
BJU INTERNATIONAL, 2023, 131 : 10 - 10
[50] Ga-68 PSMA 11 PET/MRI in Patients with Newly Diagnosed Intermediate and High-Risk Prostate Cancers
Zacharias, Claudia
Harrison, Caitlyn
Ghanouni, Pejman
Sonn, Geoffrey
Iagaru, Andrei
JOURNAL OF NUCLEAR MEDICINE, 2017, 58

← 1 2 3 4 5 →